gms | German Medical Science

73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

29.05. - 01.06.2022, Köln

Central neurocytoma – 30-day postoperative morbidity in a series of 30 patients

Zentrales Neurozytom: 30-Tage-Morbidität postoperativ bei einer Serie von 30 Patienten

Meeting Abstract

  • presenting/speaker Oday Atallah - Medizinische Hochschule Hannover, Neurochirurgie, Hannover, Deutschland
  • Shadi Al-Afif - Medizinische Hochschule Hannover, Neurochirurgie, Hannover, Deutschland
  • Amir Samii - International Neuroscience Institute, Neurochirurgie, Hannover, Deutschland
  • Madjid Samii - International Neuroscience Institute, Neurochirurgie, Hannover, Deutschland
  • I. Erol Sandalcioglu - Universitätsklinikum Magdeburg, Klinik für Neurochirurgie, Magdeburg, Deutschland
  • Belal Neyazi - Universitätsklinikum Magdeburg, Klinik für Neurochirurgie, Magdeburg, Deutschland
  • Joachim K. Krauss - Medizinische Hochschule Hannover, Neurochirurgie, Hannover, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie. Köln, 29.05.-01.06.2022. Düsseldorf: German Medical Science GMS Publishing House; 2022. DocP138

doi: 10.3205/22dgnc451, urn:nbn:de:0183-22dgnc4517

Published: May 25, 2022

© 2022 Atallah et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Neurocytomas are rare tumors. Due to their location they present a challenge for surgical treatment. We here investigated the 30-day morbidity after resection of central neurocytomas.

Methods: Analysis of demographic and clinical data of a series of 30 patients who had surgery over a 20-year period. The primary outcome determinant was the occurrence of complications within 30 days postoperatively.

Results: Eighteen patients were male (60%), 12 (40 %) were female. Mean age at surgery was 32 years (range, 12 to 84 years). A transcortical approach was chosen in 19 instances. Twenty patients had preoperative hydrocephalus and/or symptoms of increased intracranial pressure (66%). There were no intraoperative complications. An EVD was placed perioperatively in 8 patients (26.6%). Early postoperative complications occurred in 5 patients and included: ventricular hemorrhage (n=2), subdural hygroma (n=1) and neurologic deterioration (n=2).

Conclusion: The 30-day morbidity in patients with central neurocytomas is acceptable when surgery is performed in experienced hands. Management of CSF disorders in the acute phase is crucial.